Retatrutide vs Semaglutide: Which GLP-1 Drug Delivers Better Weight Loss Results?
In 2025, the world of medical weight loss is undergoing a revolution. GLP-1 receptor agonists have become global leaders in obesity management, transforming how doctors and patients approach fat loss, appetite control, and metabolic health. The two most discussed medications today are Semaglutide the established, FDA-approved therapy marketed as Ozempic and Wegovy and Retatrutide, a…
